BioRestorative Therapies
BRTXPhase 2Focused on degenerative disc disease, metabolic disorders, and aesthetic medicine, BioRestorative Therapies develops advanced stem cell-based treatments that unlock the body’s regenerative potential.
Market Cap
$6.0M
Focus
Cell & Gene Therapy
BRTX · Stock Price
USD 0.284.64 (-94.31%)
Historical price data
About
Focused on degenerative disc disease, metabolic disorders, and aesthetic medicine, BioRestorative Therapies develops advanced stem cell-based treatments that unlock the body’s regenerative potential.
Pipeline Snapshot
11 drug in pipeline
| Drug | Indication | Stage | Watch |
|---|---|---|---|
| BRTX-100 + Saline | Lumbar Disc Disease | Phase 2 |
Company Info
TypePublic
LocationUnited States
StagePhase 2
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile